EUCRU
Eucrates Biomedical Acquisition Corp. Unit
EUCRU
EUCRU
Delisted
EUCRU was delisted on the 26th of April, 2023.
4 hedge funds and large institutions have $6.72M invested in Eucrates Biomedical Acquisition Corp. Unit in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
4
Holders Change
-2
Holders Change %
-33.33%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
CS
Clear Street
New York
|
+$1.04K |
Top Sellers
| 1 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$26.3K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$3.94K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
1
Verition Fund Management
Greenwich,
Connecticut
| $4.12M | – | – | – |
|
|
SCM
2
Sio Capital Management
New York
| $2.58M | – | – | – |
|
|
CS
3
Clear Street
New York
| $28.4K | +$1.04K | +100 | +4% |
|
|
DM
4
Deerfield Management
New York
| $10 | – | – | – |
|
|
WAM
5
Wolverine Asset Management
Chicago,
Illinois
| – | -$26.3K | -2,635 | Closed |
|
|
6
UBS Group
Zurich,
Switzerland
| – | -$3.94K | -400 | Closed |
|